Volume 6, Issue 2 (Journal of Clinical and Basic Research (JCBR) 2022)                   jcbr 2022, 6(2): 12-20 | Back to browse issues page

Ethics code: The current study protocol approved by Institutional Ethics Committee, Naryana Medical College, Nell
Clinical trials code: Nil

XML Print

1- Department of Pathology, NRI Medical College, Mangalagiri, Guntur-522 503, Andhra Pradesh, India
2- Department of Pathology, Prathima institute of medical Sciences, Karimnagar, Telangana, India , research.nmch@rediffmail.com
3- Department of Pathology, Naryana Medical College, Nellore, A.P, India
4- Department of Pathology, Surabhi Institute of Medical Sciences, Siddipet, Telangana, India
Abstract:   (1441 Views)
Background and objectives: Pregnancy-induced hypertension (PIH) is a serious pregnancy complication that contributes significantly to both maternal and neonatal morbidity and mortality. The study aimed to evaluate various hematological parameters associated with PIH and to identify early hematological parameters predictive of eclampsia and hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome.
Methods: A total of 114 subjects were studied. Venous blood samples were collected to study hematological profile, including coagulation and biochemical analysis.
Results: Of 114 subjects, 35 were categorized as gestational hypertension, 33 as mild preeclampsia, 40 as severe preeclampsia, and six as eclampsia. Eight cases progressed to HELLP syndrome. The mean hemoglobin level was 10.6+2.1 g/dl, which decreased significantly in PIH patients as the disease progressed (p=0.045). The mean platelet count was 191 + 84 x 109cells/L. The mean platelet count in PIH patients decreased significantly with disease progression (p=0.008). The mean prothrombin time and activated partial thromboplastin time were 13.12 + 1.33 and 33.62 + 6.34 seconds, respectively. These parameters also increased significantly with disease progression (p<0.05). Liver enzymes, creatinine, and uric acid levels increased significantly as the disease progressed (p<0.05).
Conclusion: Most of the hematological parameters changed as PIH progressed in severity. The mean levels of hemoglobin, platelet, and lymphocytes are lower in cases with PIH, while the mean prothrombin time and activated partial thromboplastin time are higher in these patients. These variables are sensitive and specific prognostic markers for patients with PIH.
Full-Text [PDF 489 kb]   (790 Downloads) |   |   Full-Text (HTML)  (481 Views)  
Article Type: Research | Subject: Basic medical sciences
Received: 2022/02/28 | Accepted: 2022/04/27 | Published: 2022/05/9

1. Fatemeh T, Marziyeh G, Nayereh G, Anahita G, Samira T. Maternal and perinatal outcome in nulliparious women complicated with pregnancy hypertension. JPMA. The Journal of the Pakistan Medical Association. 2010 Sep 1;60(9):707. [Google Scholar]
2. Sultana F, Parthiban R, Shariff S. Thrombocytopenia in pregnancy induced hypertension. J Med Sci Health. 2015;1(2):19-24 [DOI] [Google Scholar]
3. Dutta.D.C. Hypertensive Disorders In Pregnancy. In: Hiralal, K (ed.) Textbook of Obstetrics Including . Kolkata, India: Jaypee Brothers Medical Publishers (P) Ltd; 2013.p. 219-240. [DOI]
4. Bora R, Sable C, Wolfson J, Boro K, Rao R. Prevalence of anemia in pregnant women and its effect on neonatal outcomes in Northeast India. The Journal of Maternal-Fetal & Neonatal Medicine. 2014 Jun 1;27(9):887-91. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Khan A, Fahim A, Qureshi A, Nizamani GS, Azmi MA. Pregnancy Induced Hypertension; Assessment of prognostic value of platelet count in women with varying degree. Professional Med J. 2014;21(3):436- 40. [DOI] [Google Scholar]
6. Ratnam SS, Rao KB, Arul kumaran S. Obstetrics and Gynecology for postgraduates, Vol 1. 2nd Edition. Orient Longman, Hydrabad. 1999:60.
7. Schlembach D. Pre-eclampsia--still a disease of theories. Fukushima journal of medical science. 2003;49(2):69-115. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Lescale KB, Eddleman KA, Cines DB, Samuels P, Lesser ML, McFarland JG, Bussel JB. Antiplatelet antibody testing in thrombocytopenic pregnant women. American journal of obstetrics and gynecology. 1996 Mar 1;174(3):1014-8. [View at Publisher] [DOI] [Google Scholar]
9. Karim R, Sacher RA. Thrombocytopenia in pregnancy. Current Hematology Reports. 2004 Mar 1;3(2):128-33. [View at Publisher] [Google Scholar]
10. Dhinwa M, Gawande K, Jha N, Anjali M, Bhadoria AS, Sinha S. Prevalence of hypertensive disorders of pregnancy in India: A systematic review and meta-analysis. J Med Evid. 2021 May 1;2:105-2. [DOI] [Google Scholar]
11. Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB, Goudar S, Macuacua SE, Mallapur A, Qureshi R, Sevene E, Sotunsa J. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: a prospective population-level analysis. PLoS medicine. 2019 Apr 12;16(4):e1002783. [View at Publisher] [DOI] [PMID] [PMCID] [Google Scholar]
12. Monteiro G, Subbalakshmi NK, Pai SR. Relevance of measurement of hematological parameters in subjects with pregnancy induced hypertension. Nitte University Journal of Health Science. 2014 ;4(1):15 [View at Publisher] [DOI] [Google Scholar]
13. B Namavar Jahromi, SH Rafiee. Coagulation Factors in Severe Preeclampsia. Iranian Red Crescent Medical Journal. 2009; 11(3):321-324. [View at Publisher] [Google Scholar]
14. Alisi PN, Buseri FI, Alisi CS. Some Blood Cell Changes and Alteration in Renal and Hepatic Function in Pre-eclampsia: A Study in Owerri Nigeria. IBRR 2014; 4; 132-139. [View at Publisher] [DOI] [Google Scholar]
15. Madazli R, Benian A, Gümüştaş K, Uzun H, Ocak V, Aksu F. Lipid peroxidation and antoxidants in preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology. 1999 Aug 1;85(2):205-8. [View at Publisher] [DOI] [Google Scholar]
16. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329(20):1463-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Mohapatra S, Pradhan BB, Satpathy UK, Mohanty A, Pattnaik JR. Platelet estimation: its prognostic value in pregnancy induced hypertension. Indian J Physiol Pharmacol 2007; 51 (2) : 160- 164. [Google Scholar]
18. Chaware SA, Dhake R, Ingole AS, Bahattare VN, Bhopale KS. Study of Coagulation Profile in Preeclampsia and Eclampsia. International Medical Journal. 2015;2(3):164-70. [Google Scholar]
19. Onisai M, Vladareanu AM, Bumbea H, Ciorascu M, Pop C, Andrei C, Nicolescu A, Voican I, Vasilescu S, Visan L, Adrian II. A study of the hematological picture and of platelet function in preeclampsia-report of a series of cases. Maedica-a Journal of Clinical Medicine. 2009 Dec 1;4(4). [Google Scholar]
20. Shetty J, Rao S, Kulkarni MH. Hematological Changes in Pregnancy-induced Hypertension. International journal of scientific study. 2016;4(5):215-20. [Google Scholar]
21. Nirmala T, Kumar Pradeep L, Vani B R., Murthy Srinivasa V, Geetha RL. Study Of Coagulation Profile In Pregnancy Induced Hypertension. Indian Journal Of Pathology and Oncology;2015;2(1)1-6.
22. Chauhan P, Rawat U, Bisht V, Purohit RC. Comparison of cogulation profile in pre eclamptic and eclamptic patients with normotensive pregnant patients. Journal of Evolution of Medical and Dental Sciences. 2014 Mar 24;3(12):3208-16. [DOI] [Google Scholar]
23. Dave R, Agravat A, Dhruva G, Katara A. Comparative Study of Coagulation Factors in Pre-Eclampsia and Normal Pregnancy. International Journal of Scientific Research;2014;3(4);377-378. [DOI] [Google Scholar]
24. Orlikowski CE, Rocke DA, Murray WB, Gouws E, Moodley J, Kenoyer DG, Byrne S. Thrombelastography changes in pre-eclampsia and eclampsia. British Journal of Anaesthesia. 1996;77(2):157-61. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Munazza B, Raza N, Naureen A, Khan SA, Fatima F, Ayub M, Sulaman M. Liver function tests in preeclampsia. J Ayub Med Coll Abbottabad. 2011;23(4):3-5. [Google Scholar]
26. Bhowmik DK, Akhtari R, Kumar SU, Saha M, Adhikary DK. Alteration of liver function in preeclampsia and eclampsia. Chattagram Maa-O-Shishu Hospital Medical College Journal. 2013 Oct 28;12(3):9-10. [DOI] [Google Scholar]
27. Ganai I, Shazia JS, Parveen N, Arif K, Farooq AG. To Study Biochemical and Hematological Parameters in Pre-Eclampsia; JMSCR; 2014;2(1);315-320.
28. Wakwe VC, Abudu O. Estimation of plasma uric acid in pregnancy induced hypertension (PIH). Afr J Sci. 1999:155-8. [Google Scholar]
29. Hawkins TL, Roberts JM, Mangos GJ, Davis GK, Roberts LM, Brown MA. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG 2012; 119(4):484-92. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Mustaphi R, Gopalan S, Dhaliwal L, Sarkar AK. Hyperuricemia and pregnancy induced hypertension-reappraisal. Indian J Med Sci 1996; 50 (3):68-71. [View at Publisher] [Google Scholar]
31. Sunitha T, Sameera K, Umarani G. Study of Biochemical Changes In Pre-Eclamptic Women; International Journal Of Biological & Medical Research; 2012;3(3):2025-2028. [Google Scholar]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.